Month: June 2019

Lactation cookies feed on breastfeeding anxieties

There’s little good evidence to say "lactation cookies" do anything at all. If you want cookies, eat cookies. Lactation cookies are an expensive scam.

/ June 13, 2019

Taking On the Wellness Industry

The wellness industry is just one more manifestation of quackery and pseudoscience in health.

/ June 12, 2019

Juice Plus+: Good Marketing, Not Good Science

Juice Plus+ is a multilevel marketing company selling fruits and vegetables that they have reduced to a powder and put into capsules. It's clever marketing using deceptive advertising. There is no scientific evidence that it benefits health.

/ June 11, 2019

Patients Blinded by Stem Cell Therapy: FDA (and consumers) win a legal victory!

The Food and Drug Administration just won a court case supporting the agency's ability to regulate stem cell clinics that rely on client-derived adipose tissues. This is a win for consumer protection, though too late to help those already harmed.

/ June 10, 2019

Direct to Consumer Telemedicine’s Flaws

Telemedicine is here, probably to stay, but with its arrival come new problems.

/ June 7, 2019

Walmart sued for deceiving customers in selling homeopathic remedies

A lawsuit claiming Walmart fraudulently deceives consumers in the sale of worthless homeopathic remedies has been filed by the Center for Inquiry (CFI), acting on behalf of the general public. CFI says co-mingling ineffective homeopathic products with science-based treatments on Walmart's pharmacy shelves and website misleads customers into thinking they are equivalent, when "there is not a shred of credible scientific evidence"...

/ June 6, 2019

WHO Promotes Unscientific TCM

The World Health Organization endorses quackery in the form of TCM.

/ June 5, 2019

Everlywell: At-Home Lab Tests That Don’t Make Sense

EverlyWell offers 34 at-home tests for everything from IgG tests for food sensitivities to a Sleep and Stress test. Most of them make no sense and are likely to mislead customers.

/ June 4, 2019

The FDA’s accelerated drug approval program is failing to protect cancer patients

Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a countervailing pressure to approve new drugs rapidly, particularly in cancer. That's why the FDA created the accelerated approval program in the early 1990s. Unfortunately, increasingly this approval process appears to be failing us in oncology. Reform is needed.

/ June 3, 2019